Advanced multiparametric image spectroscopy and super-resolution microscopy reveal a minimal model of CD95 signal initiation.
Bartels N, van der Voort NTM, Opanasyuk O, Felekyan S, Greife A, Shang X, Bister A, Wiek C, Seidel CAM, Monzel C.

[Porphyromonas gingivalis infection facilitates immune escape of esophageal cancer by enhancing YTHDF2-mediated Fas degradation].
Yang Z, Zhang X, Zhang X, Liu Y, Zhang J, Yuan X., Free PMC Article

Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma.
Liu Y, Sardana R, Nemirovsky D, Frosina D, Jungbluth A, Johnson WT, Vardhana S, Arcila M, Horwitz SM, Derkach A, Dogan A, Xiao W., Free PMC Article

CD95L concatemers highlight different stoichiometries of CD95-mediated apoptotic and nonapoptotic pathways.
Lebrault E, Oblet C, Kurma K, Levoin N, Jeannet R, Jean M, Vacher P, Legembre P.

CD95 promotes stemness of colorectal cancer cells by lncRNA MALAT1.
Gao C, Jia K, Fang J, Zhu X, Hu J, Zhang Y, Jiang J, Yu X, Wang D, Gu H, Chen Z.

Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells.
Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Fuentes M, Díez P, Bakardjieva M, Stancikova J, Raabe J, Neumann J, Schwenk S, Arpesella L, Stuchly J, Benes V, García Valiente R, Fernández García J, Carsetti R, Piano Mortari E, Catala A, de la Calle O, Sogkas G, Neven B, Rieux-Laucat F, Magerus A, Neth O, Olbrich P, Voll RE, Alsina L, Allende LM, Gonzalez-Granado LI, Böhler C, Thiel J, Venhoff N, Lorenzetti R, Warnatz K, Unger S, Seidl M, Mielenz D, Schneider P, Ehl S, Rensing-Ehl A, Smulski CR, Rizzi M.

Interactions of genetic variations in FAS, GJB2 and PTPRN2 are associated with noise-induced hearing loss: a case-control study in China.
Wu S, Wu Z, Chen M, Zhong X, Gu H, Du W, Liu W, Lang L, Wang J., Free PMC Article

Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing.
Rensing-Ehl A, Lorenz MR, Führer M, Willenbacher W, Willenbacher E, Sopper S, Abinun M, Maccari ME, König C, Haegele P, Fuchs S, Castro C, Kury P, Pelle O, Klemann C, Heeg M, Thalhammer J, Wegehaupt O, Fischer M, Goldacker S, Schulte B, Biskup S, Chatelain P, Schuster V, Warnatz K, Grimbacher B, Meinhardt A, Holzinger D, Oommen PT, Hinze T, Hebart H, Seeger K, Lehmberg K, Leahy TR, Claviez A, Vieth S, Schilling FH, Fuchs I, Groß M, Rieux-Laucat F, Magerus A, Speckmann C, Schwarz K, Ehl S, ALPS Study Group.

Glycemic Index, Glycemic Load, and FAS rs6586161 Polymorphism in Relation to Gastric Cancer Risk: A Case-Control Study in Korea.
Kim HK, Kim SY, Kwak JH, Kim HJ., Free PMC Article

Blood soluble Fas concentrations and ischemic stroke patient mortality.
Lorente L, Martín MM, Pérez-Cejas A, Ferrer-Moure C, Ramos-Gómez L, Solé-Violán J, Cáceres JJ, Jiménez A, González-Rivero AF.

Clinical and immunological analysis of a large kindred affected by autoimmune lymphoproliferative syndrome (ALPS) due to a novel TNFRSF6 mutation displaying age dependent disease activity.
Tessarin G, Baronio M, Gazzurelli L, Rossi S, Gorio C, Bertoni E, Chiarini M, Moratto D, Mazza C, Porta F, Badolato R, Lougaris V.

Fas cell surface death receptor/Fas ligand genetic variants in gastric cancer patients: A case-control study.
Asgari R, Bidmeshkipour A, Mansouri K, Bakhtiari M, Mozafari H, Abdolmaleki A., Free PMC Article

MiR-130a-5p contributed to the progression of endothelial cell injury by regulating FAS.
Wang W, Tang W, Shan E, Zhang L, Chen S, Yu C, Gao Y., Free PMC Article

Impact of human CD95 mutations on cell death and autoimmunity: a model.
Seyrek K, Ivanisenko NV, Wohlfromm F, Espe J, Lavrik IN.

Differential cancer risk and survival in Indian oral cancer patients with genic region FAS and FASL polymorphisms.
Daripally S, Peddi K.

Branched I antigen regulated cell susceptibility against natural killer cytotoxicity through its N-linked glycosylation and overall expression.
Wu YX, Lu HF, Lin YH, Chuang HY, Su SC, Liao YJ, Twu YC.

BEWO trophoblast cells and Toxoplasma gondii infection modulate cell death mechanisms in THP-1 monocyte cells by interference in the expression of death receptor and intracellular proteins.
da Silva Castro A, Angeloni MB, de Freitas Barbosa B, de Miranda RL, Teixeira SC, Guirelli PM, de Oliveira FC, José da Silva R, Franco PS, Ribeiro M, Milian ICB, de Oliveira Gomes A, Ietta F, Júnior SF, Mineo TWP, Mineo JR, de Oliveira Simões Alves CM, Ferro EAV.

Single Nucleotide Variant in FAS Associates With Organ Failure and Soluble Fas Cell Surface Death Receptor in Critical Illness.
Mikacenic C, Bhatraju P, Robinson-Cohen C, Kosamo S, Fohner AE, Dmyterko V, Long SA, Cerosaletti K, Calfee CS, Matthay MA, Walley KR, Russell JA, Christie JD, Meyer NJ, Christiani DC, Wurfel MM., Free PMC Article

Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population.
Guo XY, Xia YL, Li ZY, Li R, Fan Y, Yao WM, Liu F.

ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
Consonni F, Gambineri E, Favre C., Free PMC Article

High FAS expression correlates with a better prognosis and efficacy of taxanes and target regents in breast cancer.
Zhang Y, Shao X, Gao C, Xu D, Wu J, Zhu X, Chen Z.

Fas-threshold signalling in MSCs promotes pancreatic cancer progression and metastasis.
Mohr A, Chu T, Clarkson CT, Brooke GN, Teif VB, Zwacka RM.

Relationship between polymorphisms in the FAS/FASL death receptor system and progression of low-grade precursor lesions infected with high-risk human papilloma virus.
Santaclara V, Torres-Moreno D, Bernal-Mañas CM, Isaac MA, Ortiz-Reina S, Conesa-Zamora P.

Increased stability of the TM helix oligomer abrogates the apoptotic activity of the human Fas receptor.
Steindorf D, Loeuillet A, Bagnard D, Strand S, Schneider D.

The role of FAS gene variants in inflammatory bowel disease.
Demir A, Kahraman R, Candan G, Ergen A., Free PMC Article